Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,866 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 823
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +18.8%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (418)

clinicaltrialsPublishedShowing 451–500 of 2,866 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03975959	Memory Perception Assessment in Central/Non-central Nervous System Cancers(PROMESSE)	completed	N/A	426	Institut du Cancer de Montpellier - Val d'AurelleOTHER	1	Jun 4, 2026	clinicaltrials
NCT04547777	Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma	recruiting	Phase 1	90	Darell BignerOTHER	1	Jun 4, 2026	clinicaltrials